This article is more than 5 years old. Information may no longer be current.

VisiVite plans launch of macular health supplement

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

VisiVite will release ProVision, a macular health formula based on the AREDS 2 study, this spring, according to a press release from the company.

ProVision will include vitamin C 500 mg, vitamin E 400 IU, zinc 25 mg, copper 1 mg, lutein 10 mg and zeaxanthin 2 mg.

The supplement will be exclusively available from eye health providers, the company said.

"With ProVision, eye doctors get the simplicity of recommending an affordable, doctor-formulated AREDS 2 macular health supplement made by VisiVite," Paul Krawitz, MD, CEO of Vitamin Science Inc., said in the release. "Patients get an evidence-based means of supporting their vision that's affordable and easy to take: Just two easy-to-swallow softgels daily supply therapeutic antioxidant levels, and a single bottle lasts 90 days so patients only need to buy it four times per year."

ProVision will launch at Vision Expo East in New York in March. As detailed in the release, it will be available in demi-cases of 12 bottles.